ARCHIVES

Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Baque Heads Cancer Control Science Programs; Joftes, Davignon T Retire; Schepartz Returns

September 29, 1989

Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival

August 31, 2012

ODAC Unanimously Rejects Melblez, Citing Lower Survival

May 17, 2013

DCT board Oks New Cooperative Groups For MRI Evaluations In Breast Cancer

February 18, 1994

UC Davis Study Finds Patients Need Practical Information

June 28, 2002

Bonner to Succeed Stovall as NCCS President and CEO.

May 30, 2008